Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors Newsfile - Fri Dec 20, 2:22AM CST

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Provides Update on Delivery of AGSM Proxy Materials Newsfile - Mon Dec 2, 6:06PM CST

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence's Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC) Newsfile - Fri Nov 29, 5:02PM CST

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development Newsfile - Mon Nov 25, 2:20AM CST

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Announces Closing of Securities for Debenture Financing Newsfile - Fri Nov 22, 6:04PM CST

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Therapeutics Announces Securities for Debenture Financing Newsfile - Thu Nov 14, 6:36PM CST

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors Newsfile - Wed Nov 13, 2:20AM CST

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Announces Extension of Private Placement, Continues Development of Its Radiopharmaceuticals and ADC Programs Newsfile - Mon Nov 4, 5:32PM CST

Vancouver, British Columbia--(Newsfile Corp. - November 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence Therapeutics Completes 1st Tranche of Financing Newsfile - Wed Oct 30, 5:08PM CDT

Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)
Defence's Corporate Updates, Arranges Financing Newsfile - Fri Sep 27, 6:06AM CDT

Vancouver, British Columbia--(Newsfile Corp. - September 27, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.2732 (-33.93%)
DTC.CN : 0.5700 (+9.62%)

Barchart Exclusives

Love Dividends? 2 Passive Income Stocks to Scoop Up Now. Barchart - 3 minutes ago
These consistent dividend-paying stocks could be a good addition to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot